Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
253
datasets available to search
ShareScore release 0.9.0
Dataset results
253 results for “gefitinib;”
Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00824746. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma
ClinicalTrials.gov study NCT01310855. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLC
ClinicalTrials.gov study NCT01203917. IPD Sharing: Not stated. Countries: 13. Publications: 1.
ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC.
ClinicalTrials.gov study NCT01774721. IPD Sharing: YES. Countries: 7. Publications: 9.
Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma
ClinicalTrials.gov study NCT00113529. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00062062. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC
ClinicalTrials.gov study NCT02299765. IPD Sharing: Not stated. Countries: 1. Publications: 15.
Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLC
ClinicalTrials.gov study NCT04028778. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC
ClinicalTrials.gov study NCT01755923. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases
ClinicalTrials.gov study NCT00238251. IPD Sharing: Not stated. Countries: 1. Publications: 1.
MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC).
ClinicalTrials.gov study NCT02088112. IPD Sharing: YES. Countries: 3. Publications: 1.
Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
ClinicalTrials.gov study NCT00025675. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT00025350. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00217698. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations
ClinicalTrials.gov study NCT01024413. IPD Sharing: UNDECIDED. Countries: 1. Publications: 14.
Bevacizumab Combined With Gefitinib in the Treatment of Advanced NSCLC
ClinicalTrials.gov study NCT04425187. IPD Sharing: YES. Countries: 1. Publications: 1.
Alflutinib Mesylate Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer （FLAG）
ClinicalTrials.gov study NCT03787992. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01196234. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib
ClinicalTrials.gov study NCT00522145. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
ClinicalTrials.gov study NCT00025142. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.